Shandong Buchang Pharmaceuticals Co (SHSE:603858) Total Stockholders Equity : ¥11,564 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Total Stockholders Equity?

Shandong Buchang Pharmaceuticals Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥11,564 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Shandong Buchang Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥10.46. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Shandong Buchang Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.32.

Shandong Buchang Pharmaceuticals Co Total Stockholders Equity Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Total Stockholders Equity Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

13,638.32

13,690.83

14,297.71

12,362.63

11,616.99

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															12,815.57	12,046.37	12,225.44	11,616.99	11,564.29

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Shandong Buchang Pharmaceuticals Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(11564.286	-	0)	/	1106.04
	=	10.46

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Shandong Buchang Pharmaceuticals Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1131.264	+	2556.679)	/	11564.286
	=	0.32

Shandong Buchang Pharmaceuticals Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines